These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7438567)

  • 1. Measurement of complement components in cerebral spinal fluid by radioimmunoassay in patients with multiple sclerosis.
    Yam P; Petz LD; Tourtellotte WW; Ma BI
    Clin Immunol Immunopathol; 1980 Dec; 17(4):492-505. PubMed ID: 7438567
    [No Abstract]   [Full Text] [Related]  

  • 2. Relation between benign course of multiple sclerosis and low-grade humoral immune response in cerebrospinal fluid.
    Stendahl-Brodin L; Link H
    J Neurol Neurosurg Psychiatry; 1980 Feb; 43(2):102-5. PubMed ID: 7359146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid complement proteins in neurological disease.
    Price P; Cuzner ML
    J Neurol Sci; 1980 Apr; 46(1):49-54. PubMed ID: 6966324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Complement 3 level in the cerebrospinal fluid in multiple sclerosis].
    Wajgt A
    Neurol Neurochir Pol; 1980; 14(3):275-82. PubMed ID: 7412984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulin abnormalities in multiple sclerosis. Relation to clinical parameters: exacerbations and remissions.
    Olsson JE; Link H
    Arch Neurol; 1973 Jun; 28(6):392-9. PubMed ID: 4121785
    [No Abstract]   [Full Text] [Related]  

  • 6. Immune complexes and the complement factors C4 and C3 in cerebrospinal fluid and serum from patients with chronic progressive multiple sclerosis.
    Jans H; Heltberg A; Zeeberg I; Kristensen JH; Fog T; Raun NE
    Acta Neurol Scand; 1984 Jan; 69(1):34-8. PubMed ID: 6702418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid C3 and C4 indexes in immunological disorders of the central nervous system.
    Jongen PJ; Doesburg WH; Ibrahim-Stappers JL; Lemmens WA; Hommes OR; Lamers KJ
    Acta Neurol Scand; 2000 Feb; 101(2):116-21. PubMed ID: 10685859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunological parameters in multiple sclerosis].
    Igata A; Koriyama T; Matsubara H; Sano Y
    Rinsho Shinkeigaku; 1984 Dec; 24(12):1225-8. PubMed ID: 6535676
    [No Abstract]   [Full Text] [Related]  

  • 9. The determination of the complement components C1q, C4 and C3 in serum and cerebrospinal fluid by radioimmunoassay.
    Dujardin BC; Driedijk PC; Roijers AF; Out TA
    J Immunol Methods; 1985 Jun; 80(2):227-37. PubMed ID: 3925023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid complement in multiple sclerosis.
    Dube VE; McDuffie FC; Burton RC; Ilstrup D
    J Lab Clin Med; 1973 Apr; 81(4):530-7. PubMed ID: 4121212
    [No Abstract]   [Full Text] [Related]  

  • 11. High levels of C3c in the cerebrospinal fluid from amyotrophic lateral sclerosis patients.
    Annunziata P; Volpi N
    Acta Neurol Scand; 1985 Jul; 72(1):61-4. PubMed ID: 4050318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid analysis differentiates between relapsing-remitting and secondary progressive multiple sclerosis.
    Jongen PJ; Lamers KJ; Doesburg WH; Lemmens WA; Hommes OR
    J Neurol Neurosurg Psychiatry; 1997 Oct; 63(4):446-51. PubMed ID: 9343121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of laser nephelometry in the measurement of serum proteins.
    Deaton CD; Maxwell KW; Smith RS; Creveling RL
    Clin Chem; 1976 Sep; 22(9):1465-71. PubMed ID: 821678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum-complement in multiple sclerosis.
    Geraud G; de Boissezon JF; Castel M; Bes A; Geraud J
    Lancet; 1977 Dec; 2(8049):1177. PubMed ID: 73086
    [No Abstract]   [Full Text] [Related]  

  • 15. Letter: Multiple sclerosis with hypocomplementaemia.
    Trouillas P; Aimard G; Berthoux F; Devic M
    Lancet; 1975 Nov; 2(7941):932. PubMed ID: 53416
    [No Abstract]   [Full Text] [Related]  

  • 16. [CSF findings in patients with ALS].
    Takase S
    Rinsho Shinkeigaku; 1984 Dec; 24(12):1257-61. PubMed ID: 6085569
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunoglobulins and measles antibodies in optic neuritis.
    Link H; Norrby E; Olsson JE
    N Engl J Med; 1973 Nov; 289(21):1103-7. PubMed ID: 4356853
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypocomplementaemic and normocomplementaemic multiple sclerosis. Genetic determinism and association with specific HLA determinants (B18 and B7).
    Trouillas P; Betuel H
    J Neurol Sci; 1977 Jul; 32(3):425-35. PubMed ID: 886365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive viral immunology of multiple sclerosis. III. Analysis of CSF antibodies by radioimmunoassay.
    Forghani B; Cremer NE; Johnson KP; Fein G; Likosky WH
    Arch Neurol; 1980 Oct; 37(10):616-9. PubMed ID: 6252875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Terminal component of complement (C9) in cerebrospinal fluid of patients with multiple sclerosis.
    Morgan BP; Campbell AK; Compston DA
    Lancet; 1984 Aug; 2(8397):251-4. PubMed ID: 6146808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.